Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with inverse probability of treatment weighting retrospective study - Top-Institutions - MDSpire

Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with inverse probability of treatment weighting retrospective study

  • By

  • Yun Shi

  • Qiuyi Wang

  • Ziqing Ye

  • Doudou Chen

  • Tao Yang

  • Yongyue Wei

  • Xuqin Zheng

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The First Affiliated Hospital of Nanjing Medical University
    The First Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu

    Key Differentiators

    • Oncology

Original Source(s)

Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with inverse probability of treatment weighting retrospective study

  • by Yun Shi, Qiuyi Wang, Ziqing Ye, Doudou Chen, Tao Yang, Yongyue Wei, Xuqin Zheng

  • June 11, 2026

Related Content

Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy

Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review

Editorial: Exploring unconventional T cells and CAR-T-cells in cancer immunotherapy